First Cellular Therapy Approved for Type 1 Diabetes
(MedPage Today) -- The FDA has approved the first allogeneic pancreatic cell treatment for type 1 diabetes, the agency announced late on Wednesday.
Dubbed donislecel (Lantidra), the pancreatic islet cellular therapy is indicated for adults with...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Diabetes | Diabetes Type 1 | Endocrinology | International Medicine & Public Health | Pancreas